WARPTECHNEWS · LAB

Home AI Business Tech Archive

WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 150 fonti internazionali, con classificazione AI e timeline cluster su singole storie.

Navigazione

Home
Archivio
Cerca
Il tuo account
Newsletter tech/AI

Informazioni legali

Privacy Policy
Termini di servizio
Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Add-on ralinepag delays first clinical worsening event in PAH — Warptech Lab News

Add-on ralinepag delays first clinical worsening event in PAH

ORLANDO — Ralinepag, a prostacyclin receptor agonist, added to background therapy decreased the risk for a clinical worsening event in patients with pulmonary arterial hypertension, according to phase 3 ADVANCE OUTCOMES trial results.These findings were presented at the American Thoracic Society International Conference.

martedì 19 maggio 2026 New tab

1,315 words~6 min read

May 19, 2026

4 min read

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Other newsrooms on this story

· 10 sources

Full timeline →

morningstar.com·May 17, 2026 · 2 g fa
United Therapeutics Corporation Announces ADVANCE OUTCOMES Study of Ralinepag Presented at ATS 2026
medpagetoday.com·May 19, 2026 · 1 g fa
Inhaled Treprostinil Benefit Affirmed in Idiopathic Pulmonary Fibrosis
medpagetoday.com·May 19, 2026 · 1 g fa
BP Meds and Falls; Gaseous Emboli From Pulsed Field Ablation; Stent Paper Retracted
biopharmadive.com·May 19, 2026 · 1 g fa
BioMarin drug acquired in buyout misses goal in rare disease study
fiercepharma.com·May 18, 2026 · 1 g fa
AstraZeneca notches key FDA nod in hypertension, with an approval sweetener for Fasenra too
medpagetoday.com·May 18, 2026 · 2 g fa
FDA Greenlights Novel Hypertension Pill for Tough-to-Treat Patients
medpagetoday.com·May 19, 2026 · 1 g fa
Amikacin Eases MAC Lung Disease in First-Line Treatment
medpagetoday.com·May 19, 2026 · 1 g fa
Ad Insights | Care for Adults with Idiopathic Pulmonary Fibrosis or Progressive Pulmonary Fibrosis
morningstar.com·May 19, 2026 · 1 g fa
Genentech to Present New Data at ASCO 2026, Reinforcing Giredestrant's Potential to Transform the Treatment Paradigm in Early Breast Cancer
endpoints.news·May 19, 2026 · 1 g fa
BioMarin's rare disease therapy shows no clinical benefit in Phase 3 test

Related reading

morningstar.com

United Therapeutics Corporation Announces ADVANCE OUTCOMES Study of Ralinepag…

United Therapeutics Corporation Announces ADVANCE OUTCOMES Study of Ralinepag Presented at ATS 2026

morningstar.com·2 g fa

Pegtarazimod improves oxygen use, inflammatory biomarkers in acute COPD…

ORLANDO — Among hospitalized adults with acute exacerbation of COPD, pegtarazimod improved oxygen utilization and inflammatory…

healio.com·2 g fa

Nebulized LABA plus LAMA product improves FEV 1 , well tolerated in COPD

ORLANDO — Patients with COPD had larger improvements in FEV1 with a nebulized fixed-dose combination of indacaterol and…

healio.com·14 h fa

Asthma outcomes improve for diverse patients in real world with tezepelumab

ORLANDO — Patients with severe asthma who are typically underrepresented in clinical studies experienced improved outcomes with…

healio.com·1 g fa

Rapid evolution of antithrombotic therapy in the HeartMate3 era: What you…

Since the introduction of durable left ventricular assist devices for advanced heart failure, management of antithrombotic…

healio.com·14 h fa

Biologic initiation, adherence rates in asthma deemed low

ORLANDO — Initiation of biologic treatment for asthma is low despite availability, and adherence is low as well despite its…

healio.com·2 g fa